GSB Wealth Management’s CVS Health CVS Stock Holding History

GSB Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,951	Closed	-$563K	–	220
2024 Q3	$563K	Sell	8,951 -2,122	-19%	-$124K	0.14%	137
2024 Q2	$654K	Sell	11,073 -4,721	-30%	-$295K	0.18%	123
2024 Q1	$1.26M	Sell	15,794 -4,137	-21%	-$316K	0.35%	92
2023 Q4	$1.57M	Sell	19,931 -2,384	-11%	-$170K	0.48%	72
2023 Q3	$1.56M	Sell	22,315 -16,140	-42%	-$1.14M	0.52%	65
2023 Q2	$2.66M	Sell	38,455 -2,247	-6%	-$160K	0.86%	32
2023 Q1	$3.02M	Sell	40,702 -3,625	-8%	-$304K	0.99%	22
2022 Q4	$4.13M	Sell	44,327 -8,801	-17%	-$849K	1.47%	8
2022 Q3	$5.07M	Sell	53,128 -4,007	-7%	-$397K	1.84%	6
2022 Q2	$5.29M	Sell	57,135 -2,932	-5%	-$286K	1.8%	6
2022 Q1	$6.08M	Sell	60,067 -1,106	-2%	-$116K	1.77%	6
2021 Q4	$6.31M	Buy	61,173 +18,313	+43%	+$1.69M	1.81%	6
2021 Q3	$3.64M	Sell	42,860 -23,365	-35%	-$1.96M	1.87%	11
2021 Q2	$5.53M	Buy	66,225 +607	+0.9%	+$49.7K	1.72%	6
2021 Q1	$4.94M	Buy	+65,618	New	+$4.78M	1.64%	6

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

GSB Wealth Management's CVS Position: Q4 2024 in Review

GSB Wealth Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 8,951 shares — an estimated $563K sold.

GSB Wealth Management first reported a position in CVS in Q1 2021 and held it in 15 quarters. The position peaked at $6.31M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

GSB Wealth Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
GSB Wealth Management sold 8,951 CVS Health shares in Q4 2024, an estimated $563K.
GSB Wealth Management first reported a position in CVS Health in Q1 2021 and held it in 15 quarters.
GSB Wealth Management's CVS Health position peaked at $6.31M in Q4 2021.
1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on GSB Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.